EZH2-IN-2 |
| Katalog-Nr.GC39595 |
EZH2-IN-2 ist ein EZH2-Inhibitor, extrahiert aus Patent WO2018133795A1, Verbindungsbeispiel 69, mit einem IC50 von 64 nM. EZH2-IN-2 kann fÜr die Erforschung von Krebs oder Krebsvorstufen im Zusammenhang mit der EZH2-AktivitÄt verwendet werden.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2238821-31-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
EZH2-IN-2 is a EZH2 inhibitor extracted from patent WO2018133795A1, Compound Example 69, with an IC50 of 64 nM. EZH2-IN-2 can be used for the research of cancer or precancerous condition related to EZH2 activity[1].
[1]. LIU, Qing Song, et al. Ezh2 inhibitor and use thereof. WO2018133795A1.
Average Rating: 5 (Based on Reviews and 2 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *